Table of Contents:
Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
Chapter 3. Menopause Market: By Product Type Market Trends, Size, and Future Outlook
- By Product Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Product Type Definitions, Technology Landscape
- By Product Type Market Drivers
- Product Launches
- Technology Launches
- By Product Type Market Restraints
Chapter 4. Menopause Market: By Route of Administration Market Trends, Size, and Future Outlook
- By Route of Administration Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Route of Administration Definitions, Technology Landscape
- By Route of Administration Market Drivers
- Product Launches
- Technology Launches
- By Route of Administration Market Restraints
Chapter 5. Menopause Market: By Distribution Channel Market Trends, Size, and Future Outlook
- By Distribution Channel Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Distribution Channel Definitions, Technology Landscape
- By Distribution Channel Market Drivers
- Product Launches
- Technology Launches
- By Distribution Channel Market Restraints
Chapter 6. Menopause Market: By Treatment Type Market Trends, Size, and Future Outlook
- By Treatment Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Treatment Type Definitions, Technology Landscape
- By Treatment Type Market Drivers
- Product Launches
- Technology Launches
- By Treatment Type Market Restraints
Chapter 7. Menopause Market: By End-User Market Trends, Size, and Future Outlook
- By End-User Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By End-User Definitions, Technology Landscape
- By End-User Market Drivers
- Product Launches
- Technology Launches
- By End-User Market Restraints
Chapter 8. Menopause Market: By Therapy Market Trends, Size, and Future Outlook
- By Therapy Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Therapy Definitions, Technology Landscape
- By Therapy Market Drivers
- Product Launches
- Technology Launches
- By Therapy Market Restraints
Chapter 9. Menopause Market: Regional Market Trends, Size, and Future Outlook
- North America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Europe
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Asia Pacific
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Latin America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Middle East, and Africa
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
Chapter 10. Menopause Market: Competitive Landscape
- Pfizer Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Novartis AG
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Merck & Co., Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bayer AG
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Allergan plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Novo Nordisk A/S
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Eli Lilly and Company
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Amgen Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Mylan N.V.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Hikma Pharmaceuticals PLC
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- TherapeuticsMD, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Mithra Pharmaceuticals
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Astellas Pharma Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Ferring Pharmaceuticals
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Shionogi Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Kyowa Kirin Co., Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Gedeon Richter Plc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Theramex
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Lupin Limited
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the Menopause industry is US$ 14.2 billion.
Increasing aging female population globally, Rising awareness about menopause, Growing demand for effective treatments, Supportive government initiatives, Increasing research and development activities, Advances in diagnostic techniques, Availability of novel therapies, Improving healthcare infrastructure, Increasing disposable income, Expansion of healthcare coverage.
Risks associated with hormone replacement therapy, High cost of treatments, Lack of awareness in developing regions, Stigma and misconceptions surrounding menopause, Stringent regulatory requirements, Limited reimbursement policies, Preference for alternative therapies.
The leading component segment in the Menopause Market is the Hormonal Therapy segment, used to alleviate menopausal symptoms.
Pfizer Inc., Novartis AG, Merck & Co., Inc., Bayer AG, Allergan plc, Novo Nordisk A/S, Eli Lilly and Company, Amgen Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd.
The North America region is expected to lead the Menopause Market with a market share of 38.2% in 2023.
Aging female population globally, Rising awareness about menopause, Growing demand for effective treatments, Supportive government initiatives, Increasing research and development activities, Advances in diagnostic techniques, Availability of novel therapies, Improving healthcare infrastructure.